Surfactant treatment in experimental Escherichia coli pneumonia

Acta Anaesthesiologica Scandinavica

Volumn 40, Issue 9, 1996, Pages 1154-1160

  Song, G W ^a   Robertson, B ^b   Curstedt, T ^c   Gan, X Z ^a   Huang, W X ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Escherichia coli; Pneumonia; Pulmonary surfactants; Rats; Respiratory function tests

Indexed keywords

LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG RESEARCH; ESCHERICHIA COLI; LUNG FUNCTION TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE OXYGENATION;

EID: 0029854318     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1996.tb05580.x     Document Type: Article

References (35)

1. Gotoff SP. Infections of the newborn. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan III VC, eds. Nelson Textbook of Pediatrics. Philadelphia: WB Saunders Company, 1992: 495-524.
2. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 1987: 62: 429-437.
3. Seeger W, Stöhr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985: 58: 326-338.
4. Pison U, Tam EK, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 1989: 992: 251-257.
5. Van Daal GJ, Bos JAH, Eijking EP, Gommers D, Hannappel E, Lachmann B. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am Rev Respir Dis 1992:145: 859-863.
6. Van Daal GJ, So KL, Gommers D, Eijking EP, Fievéz RB, Sprenger MJ, et al. Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth Analg 1991: 72: 589-595.
7. Eijking EP, van Daal GJ, Tenbrinck R, Luijendijk A, Sluiters JF, Hannappel E, et al. Effect of surfactant replacement on pneumocystis carinii pneumonia in rats. Intensive Care Med 1991: 17: 475-478.
8. Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 1994: 36: 784-791.
9. Robertson B, Curstedt T, Johansson J, Jörnvall H, Kobayashi T. Structural and functional characterization of porcine surfactant isolated by liquid-gel chromatography. Prog Respir Res 1990: 25: 237-246.
10. Sun B, Kobayashi T, Curstedt T, Grossmann G, Robertson B. Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. Eur Respir J 1991: 4: 364-370.
11. Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics 1988: 82: 683-691.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951: 193: 265-275.
13. Bartlett GB. Phosphorus assay in column chromatography. J Biol Chem 1959: 234: 466-468.
14. Torday J, Carson L, Lawson EE. Saturated phosphatidylcholine in amniotic fluid and predictions of the respiratory-distress syndrome. N Engl J Med 1979: 301: 1013-1018.
15. Pison U, Bock JC, Pietschmann S, Veit S, Slama K. The adult respiratory distress syndrome: pathophysiological concepts related to the pulmonary surfactant system. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York: Marcel Dekker, 1995: 169-198.
16. Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruch J, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990: 30: 19-26.
17. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991: 88: 1976-1981.
18. Seeger W, Pison U, Buchhorn R, Obertacke U, Joka T. Surfactant abnormalities and adult respiratory failure. Lung 1990: 168 (Suppl): 891-902.
19. Holm BA, Notter RH, Siegle J, Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol 1985: 59: 1402-1409.
20. Young SL, Crapo JP, Kremers SA, Brumley GW. Pulmonary surfactant lipid production in oxygen-exposed rat lungs. Lab Invest 1982: 46: 570-576.
21. Low RB, Alder KB, Woodcock-Mitchell J, Grancola MS, Vacek PM. Bronchoalveolar lavage lipids during development of bleomycin induced fibrosis in rats. Relationship to altered epithelial cell morphology. Am Rev Respir Dis 1988: 138: 709-713.
22. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 1991: 29: 353-356.
23. Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994: 20: 6-11.
24. Keough KMW, Parsons CS, Phang PT, Tweeddale MG. Interactions between plasma proteins and pulmonary surfactant: Surface balance studies. Can J Physiol Pharmacol 1988: 66: 1166-1173.
25. Moses D, Holm BA, Spitale P, Liu M, Enhorning G. Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol 1991: 164: 477-481.
26. Robertson B. Surfactant replacement and neonatal lung pathology. Perspect Pediatr Pathol 1995: 18: 5-31.
27. Ennema JJ, Kobayashi T, Robertson B, Curstedt T. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol Scand 1988: 32: 665-671.
28. Matalon S, Holm BA, Notter RH. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol 1987: 62: 756-761.
29. Berggren P, Lachmann B, Curstedt T, Grossmann G, Robertson B. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol Scand 1986: 30: 321-328.
30. Strohmaier W, Schlay G. Experimental aspiration trauma: comparison of steroid treatment versus exogenous natural surfactant. Exp Lung Res 1993:19: 397-405.
31. Sun B, Herting E, Curstedt T, Robertson B. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. J Appl Physiol 1994: 77: 1961-1971.
32. Davis JM, Veness-Meehan K, Notter RH, Bhutani VK, Kendig JW, Shapiro DL. Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. N Engl J Med 1988: 319: 476-479.
33. Couser RJ, Ferrera BT, Ebert J, Hoekstra RE, Fangham JJ. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr 1990: 116: 119-124.
34. Bhat R, Dziedzic K, Bhutani VK, Vidyasagar D. Effect of single dose surfactant on pulmonary function. Crit Care Med 1990: 18: 590-595.
35. Baraldi E, Pettenazzo A, Filippone M, Magagnin GP, Saia OS, Zacchello F. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 1993: 15: 157-162.